View Archive »
About The Cover
Targeting the SIN3A-PF1 interaction inhibits epithelial to mesenchymal transition and maintenance of a stem cell phenotype in triple negative breast cancer. See Bansal et al.
|
|
Table of Contents
Editorial
|
| Dendritic cell metabolism: immunity and tolerance |
|
https://doi.org/10.18632/oncotarget.5865
|
| 34039-34040 |
|
| Naa10 in development and disease |
|
https://doi.org/10.18632/oncotarget.5867
|
| 34041-34042 |
|
| Vinculincell membrane interactions |
|
https://doi.org/10.18632/oncotarget.5868
|
| 34043-34044 |
|
| Reducing genomic instability in iPSCs |
|
https://doi.org/10.18632/oncotarget.6212
|
| 34045-34046 |
|
| Targeting lymphatics in inflammatory bowel disease |
|
https://doi.org/10.18632/oncotarget.6026
|
| 34047-34048 |
|
| DNA methylation and demethylation dynamics |
|
https://doi.org/10.18632/oncotarget.6039
|
| 34049-34050 |
|
| DCIR in the “osteoimmune†system |
|
https://doi.org/10.18632/oncotarget.6043
|
| 34051-34052 |
|
| CCN1 in hepatobiliary injury repair |
|
https://doi.org/10.18632/oncotarget.6079
|
| 34053-34054 |
|
| ASK “to be or not to be†|
|
https://doi.org/10.18632/oncotarget.6105
|
| 34055-34056 |
|
| Targeting RIPK123 to combat inflammation |
|
https://doi.org/10.18632/oncotarget.6106
|
| 34057-34058 |
|
| microRNAs calibrate T cell responses by regulating mTOR |
|
https://doi.org/10.18632/oncotarget.6107
|
| 34059-34060 |
|
| TRIB3P62 interaction diabetes and autophagy |
|
https://doi.org/10.18632/oncotarget.6108
|
| 34061-34062 |
Editorial: Immunology
|
| CXCL14: the Swiss army knife chemokine |
|
https://doi.org/10.18632/oncotarget.6040
|
| 34065-34066 |
Editorial: Autophagy and Cell Death
|
| Autophagy microbiota and intestinal oncogenesis |
|
https://doi.org/10.18632/oncotarget.5966
|
| 34067-34068 |
Editorial: Chromosome
|
| NTHL1 defines novel cancer syndrome |
|
https://doi.org/10.18632/oncotarget.5864
|
| 34069-34070 |
Priority Research Papers
|
| Effects of a novel Nodaltargeting monoclonal antibody in melanoma |
|
https://doi.org/10.18632/oncotarget.6049
|
| 34071-34086 |
|
| Targeting the SIN3APF1 interaction inhibits epithelial to mesenchymal transition and maintenance of a stem cell phenotype in triple negative breast cancer |
|
https://doi.org/10.18632/oncotarget.6048
|
| 34087-34105 |
Research Papers: Gerotarget (Focus on Aging)
|
| Identification of ageingassociated naturally occurring peptides in human urine |
|
https://doi.org/10.18632/oncotarget.5896
|
| 34106-34117 |
|
| Aging with ING: a comparative study of different forms of stress induced premature senescence |
|
https://doi.org/10.18632/oncotarget.5947
|
| 34118-34127 |
|
| Gavage of DRibose induces Aβlike deposits Tau hyperphosphorylation as well as memory loss and anxietylike behavior in mice |
|
https://doi.org/10.18632/oncotarget.6021
|
| 34128-34142 |
|
| Suppression of FoxO6 by lipopolysaccharide in aged rat liver |
|
https://doi.org/10.18632/oncotarget.6219
|
| 34143-34157 |
Research Papers: Pathology
|
| Copper activates HIF1α/GPER/VEGF signalling in cancer cells |
|
https://doi.org/10.18632/oncotarget.5779
|
| 34158-34177 |
Research Papers: Immunology
|
| Imprint of 5azacytidine on the natural killer cell repertoire during systemic treatment for highrisk myelodysplastic syndrome |
|
https://doi.org/10.18632/oncotarget.6213
|
| 34178-34190 |
Research Papers: Autophagy and Cell Death
|
| Overexpression of Bcl2 induces STAT3 activation via an increase in mitochondrial superoxide |
|
https://doi.org/10.18632/oncotarget.5763
|
| 34191-34205 |
Research Papers
|
| The Vacuolar ATPase a2subunit regulates Notch signaling in triplenegative breast cancer cells |
|
https://doi.org/10.18632/oncotarget.5275
|
| 34206-34220 |
|
| Comprehensive cancergene panels can be used to estimate mutational load and predict clinical benefit to PD1 blockade in clinical practice |
|
https://doi.org/10.18632/oncotarget.5950
|
| 34221-34227 |
|
| Activin a signaling regulates cell invasion and proliferation in esophageal adenocarcinoma |
|
https://doi.org/10.18632/oncotarget.5349
|
| 34228-34244 |
|
| JAK2 tyrosine kinase mediates integrin activation induced by CXCL12 in Bcell chronic lymphocytic leukemia |
|
https://doi.org/10.18632/oncotarget.5196
|
| 34245-34257 |
|
| Arenobufagin intercalates with DNA leading to G2 cell cycle arrest via ATM/ATR pathway |
|
https://doi.org/10.18632/oncotarget.5545
|
| 34258-34275 |
|
| Detection of recurrent cytogenetic aberrations in multiple myeloma: A comparison between MLPA and iFISH |
|
https://doi.org/10.18632/oncotarget.5371
|
| 34276-34287 |
|
| Cetuximab promotes epithelial to mesenchymal transition and cancer associated fibroblasts in patients with head and neck cancer |
|
https://doi.org/10.18632/oncotarget.5924
|
| 34288-34299 |
|
| Comprehensive investigation of oncogenic driver mutations in Chinese nonsmall cell lung cancer patients |
|
https://doi.org/10.18632/oncotarget.5549
|
| 34300-34308 |
|
| TTK activates Akt and promotes proliferation and migration of hepatocellular carcinoma cells |
|
https://doi.org/10.18632/oncotarget.5295
|
| 34309-34320 |
|
| PhosphoERK1/2 levels in cancer cell nuclei predict responsiveness to radiochemotherapy of rectal adenocarcinoma |
|
https://doi.org/10.18632/oncotarget.5761
|
| 34321-34328 |
|
| Mature adipocytes in bone marrow protect myeloma cells against chemotherapy through autophagy activation |
|
https://doi.org/10.18632/oncotarget.6020
|
| 34329-34341 |
|
| Structural basis for the indispensable role of a unique zinc finger motif in LNX2 ubiquitination |
|
https://doi.org/10.18632/oncotarget.5326
|
| 34342-34357 |
|
| The androgen receptor controls expression of the cancerassociated sTn antigen and cell adhesion through induction of ST6GalNAc1 in prostate cancer |
|
https://doi.org/10.18632/oncotarget.6024
|
| 34358-34374 |
|
| Variation in human cancer cell external phosphatidylserine is regulated by flippase activity and intracellular calcium |
|
https://doi.org/10.18632/oncotarget.6045
|
| 34375-34388 |
|
| Clusterin a gene enriched in intestinal stem cells is required for L1mediated colon cancer metastasis |
|
https://doi.org/10.18632/oncotarget.5360
|
| 34389-34401 |
|
| The Gproteincoupled bile acid receptor Gpbar1 TGR5 suppresses gastric cancer cell proliferation and migration through antagonizing STAT3 signaling pathway |
|
https://doi.org/10.18632/oncotarget.5353
|
| 34402-34413 |
|
| The radiosensitivity index predicts for overall survival in glioblastoma |
|
https://doi.org/10.18632/oncotarget.5437
|
| 34414-34422 |
|
| Downregulation of miR1295p via the Twist1Snail feedback loop stimulates the epithelialmesenchymal transition and is associated with poor prognosis in breast cancer |
|
https://doi.org/10.18632/oncotarget.5406
|
| 34423-34436 |
|
| TP53 and MDM2 single nucleotide polymorphisms influence survival in nondel5q myelodysplastic syndromes |
|
https://doi.org/10.18632/oncotarget.5255
|
| 34437-34445 |
|
| MicroRNA212 negatively regulates starvation induced autophagy in prostate cancer cells by inhibiting SIRT1 and is a modulator of angiogenesis and cellular senescence |
|
https://doi.org/10.18632/oncotarget.5920
|
| 34446-34457 |
|
| Targeting of cytosolic phospholipase A2α impedes cell cycle reentry of quiescent prostate cancer cells |
|
https://doi.org/10.18632/oncotarget.5277
|
| 34458-34474 |
|
| Characterization of adiposederived stem cells from subcutaneous and visceral adipose tissues and their function in breast cancer cells |
|
https://doi.org/10.18632/oncotarget.5922
|
| 34475-34493 |
|
| Cancer stem cell related markers of radioresistance in head and neck squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.5417
|
| 34494-34509 |
|
| RASSF8 downregulation promotes lymphangiogenesis and metastasis in esophageal squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.5923
|
| 34510-34524 |
|
| Characterisation of inflammatory processes in Helicobacter pyloriinduced gastric lymphomagenesis in a mouse model |
|
https://doi.org/10.18632/oncotarget.5948
|
| 34525-34536 |
|
| Cytotoxic T cell responses are enhanced by antigen design involving the presentation of MUC1 peptide on cholera toxin B subunit |
|
https://doi.org/10.18632/oncotarget.5307
|
| 34537-34548 |
|
| LGR5 is associated with tumor aggressiveness in papillary thyroid cancer |
|
https://doi.org/10.18632/oncotarget.5330
|
| 34549-34560 |
|
| Antitumor activity of a potent MEK inhibitor TAK733 against colorectal cancer cell lines and patient derived xenografts |
|
https://doi.org/10.18632/oncotarget.5949
|
| 34561-34572 |
|
| Homozygous mdm2 SNP309 cancer cells with compromised transcriptional elongation at p53 target genes are sensitive to induction of p53independent cell death |
|
https://doi.org/10.18632/oncotarget.5312
|
| 34573-34591 |
|
| ILKAP ILK and PINCH1 control cell survival of p53wildtype glioblastoma cells after irradiation |
|
https://doi.org/10.18632/oncotarget.5423
|
| 34592-34605 |
|
| FXR induces SOCS3 and suppresses hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.5314
|
| 34606-34616 |
|
| Evaluation of a novel human IgG1 anticlaudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery |
|
https://doi.org/10.18632/oncotarget.5315
|
| 34617-34628 |
|
| Identification of thyroid tumor cell vulnerabilities through a siRNAbased functional screening |
|
https://doi.org/10.18632/oncotarget.5282
|
| 34629-34648 |
|
| A radiosensitivity MiRNA signature validated by the TCGA database for head and neck squamous cell carcinomas |
|
https://doi.org/10.18632/oncotarget.5299
|
| 34649-34657 |
|
| Wnt activated βcatenin and YAP proteins enhance the expression of noncoding RNA component of RNase MRP in colon cancer cells |
|
https://doi.org/10.18632/oncotarget.5778
|
| 34658-34668 |
|
| The BET bromodomain inhibitor JQ1 facilitates cFLIP degradation and enhances TRAILinduced apoptosis independent of BRD4 and cMyc inhibition |
|
https://doi.org/10.18632/oncotarget.5785
|
| 34669-34679 |
|
| Next generation sequencing in synovial sarcoma reveals novel gene mutations |
|
https://doi.org/10.18632/oncotarget.5786
|
| 34680-34690 |
|
| The knockdown of H19lncRNA reveals its regulatory role in pluripotency and tumorigenesis of human embryonic carcinoma cells |
|
https://doi.org/10.18632/oncotarget.5787
|
| 34691-34703 |
|
| The transcription factor cFos coordinates with histone lysinespecific demethylase 2A to activate the expression of cyclooxygenase2 |
|
https://doi.org/10.18632/oncotarget.5474
|
| 34704-34717 |
|
| STIP is a critical nuclear scaffolding protein linking USP7 to p53Mdm2 pathway regulation |
|
https://doi.org/10.18632/oncotarget.5303
|
| 34718-34731 |
|
| Visualizing the antivascular effect of bortezomib on the hypoxic tumor microenvironment |
|
https://doi.org/10.18632/oncotarget.5300
|
| 34732-34744 |
|
| A functional variant in HOXA11AS a novel long noncoding RNA inhibits the oncogenic phenotype of epithelial ovarian cancer |
|
https://doi.org/10.18632/oncotarget.5784
|
| 34745-34757 |
|
| CCL18 from tumorassociated macrophages promotes angiogenesis in breast cancer |
|
https://doi.org/10.18632/oncotarget.5325
|
| 34758-34773 |
|
| Systemic delivery of HER2retargeted oncolyticHSV by mesenchymal stromal cells protects from lung and brain metastases |
|
https://doi.org/10.18632/oncotarget.5793
|
| 34774-34787 |
|
| PAR1 participates in the ability of multidrug resistance and tumorigenesis by controlling HippoYAP pathway |
|
https://doi.org/10.18632/oncotarget.5858
|
| 34788-34799 |
|
| Protein kinase CK2α catalytic subunit is overexpressed and serves as an unfavorable prognostic marker in primary hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.5470
|
| 34800-34817 |
|
| Inhibition of endoplasmic reticulum chaperone protein glucoseregulated protein 78 potentiates antiangiogenic therapy in renal cell carcinoma through inactivation of the PERK/eIF2α pathway |
|
https://doi.org/10.18632/oncotarget.5397
|
| 34818-34830 |
|
| CD147 reinforces [Ca2+]i oscillations and promotes oncogenic progression in hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.5225
|
| 34831-34845 |
|
| Transient rRNA synthesis inhibition with CX5461 is sufficient to elicit growth arrest and cell death in acute lymphoblastic leukemia cells |
|
https://doi.org/10.18632/oncotarget.5413
|
| 34846-34858 |
|
| Targeting EMP3 suppresses proliferation and invasion of hepatocellular carcinoma cells through inactivation of PI3K/Akt pathway |
|
https://doi.org/10.18632/oncotarget.5414
|
| 34859-34874 |
|
| A vesicular stomatitis virus glycoprotein epitopeincorporated oncolytic adenovirus overcomes CARdependency and shows markedly enhanced cancer cell killing and suppression of tumor growth |
|
https://doi.org/10.18632/oncotarget.5332
|
| 34875-34891 |
|
| Targeting MCM2 function as a novel strategy for the treatment of highly malignant breast tumors |
|
https://doi.org/10.18632/oncotarget.5408
|
| 34892-34909 |
|
| The oncolytic peptide LTX315 induces cell death and DAMP release by mitochondria distortion in human melanoma cells |
|
https://doi.org/10.18632/oncotarget.5308
|
| 34910-34923 |
|
| CREB1driven expression of miR320a promotes mitophagy by downregulating VDAC1 expression during serum starvation in cervical cancer cells |
|
https://doi.org/10.18632/oncotarget.5318
|
| 34924-34940 |
|
| Estradiol induces apoptosis via activation of miRNA23a and p53: implication for gender difference in liver cancer development |
|
https://doi.org/10.18632/oncotarget.5472
|
| 34941-34952 |
|
| Skp1 in lung cancer: clinical significance and therapeutic efficacy of its small molecule inhibitors |
|
https://doi.org/10.18632/oncotarget.5547
|
| 34953-34967 |
|
| miR200c inhibits breast cancer proliferation by targeting KRAS |
|
https://doi.org/10.18632/oncotarget.5198
|
| 34968-34978 |
|
| HPV16E2 induces prophase arrest and activates the cellular DNA damage response in vitro and in precursor lesions of cervical carcinoma |
|
https://doi.org/10.18632/oncotarget.5512
|
| 34979-34991 |
|
| Intracellular activation of EGFR by fatty acid synthase dependent palmitoylation |
|
https://doi.org/10.18632/oncotarget.5252
|
| 34992-35003 |
|
| Valproic acid enhances the efficacy of radiation therapy by protecting normal hippocampal neurons and sensitizing malignant glioblastoma cells |
|
https://doi.org/10.18632/oncotarget.5253
|
| 35004-35022 |
|
| Cytokineinduced killer cells efficiently kill stemlike cancer cells of nasopharyngeal carcinoma via the NKG2Dligands recognition |
|
https://doi.org/10.18632/oncotarget.5280
|
| 35023-35039 |
|
| Proton pump inhibitors enhance the effects of cytotoxic agents in chemoresistant epithelial ovarian carcinoma |
|
https://doi.org/10.18632/oncotarget.5319
|
| 35040-35050 |
Clinical Research Papers
|
| Reirradiation for locally recurrent refractory breast cancer |
|
https://doi.org/10.18632/oncotarget.6036
|
| 35051-35062 |
|
| Multibeam inverse intensitymodulated radiotherapy IMRT for whole breast irradiation: a single center experience in China |
|
https://doi.org/10.18632/oncotarget.5278
|
| 35063-35072 |
|
| Antiαenolase is a prognostic marker in postoperative lung cancer patients |
|
https://doi.org/10.18632/oncotarget.5316
|
| 35073-35086 |
|
| The value of lactate dehydrogenase serum levels as a prognostic and predictive factor for advanced pancreatic cancer patients receiving sorafenib |
|
https://doi.org/10.18632/oncotarget.5197
|
| 35087-35094 |
|
| Pretransplant weight loss predicts inferior outcome after allogeneic stem cell transplantation in patients with myelodysplastic syndrome |
|
https://doi.org/10.18632/oncotarget.4805
|
| 35095-35106 |
|
| S1 plus cisplatin versus fluorouracil plus cisplatin in advanced gastric or gastroesophageal junction adenocarcinoma patients: a pilot study |
|
https://doi.org/10.18632/oncotarget.5959
|
| 35107-35115 |
|
| Elevated expression of Cripto1 correlates with poor prognosis in hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.5057
|
| 35116-35128 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLC
